Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Change in Account Payables (2020 - 2024)

Historic Change in Account Payables for Quipt Home Medical (QIPT) over the last 5 years, with Q2 2024 value amounting to $1.5 million.

  • Quipt Home Medical's Change in Account Payables rose 20266.39% to $1.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $2.3 million, marking a year-over-year decrease of 1946.1%. This contributed to the annual value of $3.2 million for FY2023, which is 952.71% up from last year.
  • Quipt Home Medical's Change in Account Payables amounted to $1.5 million in Q2 2024, which was up 20266.39% from $638000.0 recorded in Q3 2023.
  • In the past 5 years, Quipt Home Medical's Change in Account Payables ranged from a high of $2.7 million in Q1 2021 and a low of -$3.1 million during Q4 2020
  • For the 5-year period, Quipt Home Medical's Change in Account Payables averaged around $358692.3, with its median value being $740000.0 (2022).
  • Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 44805.19% in 2021, then surged by 48483.41% in 2022.
  • Quipt Home Medical's Change in Account Payables (Quarter) stood at -$3.1 million in 2020, then soared by 54.64% to -$1.4 million in 2021, then surged by 214.04% to $1.6 million in 2022, then crashed by 60.71% to $638000.0 in 2023, then surged by 135.58% to $1.5 million in 2024.
  • Its Change in Account Payables stands at $1.5 million for Q2 2024, versus $638000.0 for Q3 2023 and -$1.5 million for Q2 2023.